Business
Australia to consider EU and UK findings over AstraZeneca Covid vaccine and blood clots – The Guardian
Review follows a UK decision to offer people under 30 an alternative jab following formal link to rare blood clots
Vaccines and immunisation
Australian authorities will review the findings of British and European regulators over concerns about the AstraZeneca Covid-19 vaccine but continue to emphasise that the benefits outweigh the risks.
The review follows a decision in the United Kingdom to offer healthy adults aged under 30 an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.
The European Medicines Agency also announced on Wednesday that the rare blood clots would be listed…
-
Business22 hours agoDown more than 20% this year, does Macquarie rate Boss Energy shares a buy?
-
General24 hours agoKids unknowingly targeted with AI abuse apps, images
-
Noosa News22 hours agoThe small patch of paddock emitting 10,000 cars’ worth of methane
-
Business23 hours agoGuess which ASX 200 stock is rocketing on big US news